Merit Financial Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
+2,449
| New | +$203K | ﹤0.01% | 1553 |
|
|
2024
Q3 | – | Sell |
-2,317
| Closed | -$215K | – | 972 |
|
|
2024
Q2 | $215K | Buy |
+2,317
| New | +$215K | ﹤0.01% | 847 |
|
|
2024
Q1 | – | Sell |
-2,461
| Closed | -$220K | – | 930 |
|
|
2023
Q4 | $220K | Sell |
2,461
-2,046
| -45% | -$183K | 0.01% | 702 |
|
|
2023
Q3 | $329K | Sell |
4,507
-825
| -15% | -$60.2K | 0.01% | 558 |
|
|
2023
Q2 | $444K | Sell |
5,332
-4,716
| -47% | -$392K | 0.01% | 492 |
|
|
2023
Q1 | $766K | Buy |
10,048
+535
| +6% | +$40.8K | 0.03% | 321 |
|
|
2022
Q4 | $790K | Buy |
9,513
+6,200
| +187% | +$515K | 0.03% | 332 |
|
|
2022
Q3 | $263K | Sell |
3,313
-1,000
| -23% | -$79.4K | 0.01% | 464 |
|
|
2022
Q2 | $320K | Sell |
4,313
-980
| -19% | -$72.7K | 0.01% | 427 |
|
|
2022
Q1 | $476K | Sell |
5,293
-36,836
| -87% | -$3.31M | 0.03% | 242 |
|
|
2021
Q4 | $4.72M | Sell |
42,129
-5,919
| -12% | -$663K | 0.46% | 25 |
|
|
2021
Q3 | $6.04M | Sell |
48,048
-11,632
| -19% | -$1.46M | 0.63% | 17 |
|
|
2021
Q2 | $8.08M | Buy |
59,680
+4,496
| +8% | +$609K | 0.76% | 13 |
|
|
2021
Q1 | $7.49M | Buy |
55,184
+3,100
| +6% | +$421K | 0.78% | 10 |
|
|
2020
Q4 | $7.33M | Buy |
52,084
+4,516
| +9% | +$636K | 0.71% | 9 |
|
|
2020
Q3 | $5.3M | Buy |
47,568
+11,246
| +31% | +$1.25M | 0.48% | 13 |
|
|
2020
Q2 | $4.07M | Buy |
36,322
+22,922
| +171% | +$2.57M | 0.4% | 18 |
|
|
2020
Q1 | $1.04M | Buy |
13,400
+466
| +4% | +$36.1K | 0.12% | 75 |
|
|
2019
Q4 | $1.23M | Sell |
12,934
-225
| -2% | -$21.4K | 0.11% | 74 |
|
|
2019
Q3 | $1M | Buy |
13,159
+7,231
| +122% | +$551K | 0.11% | 50 |
|
|
2019
Q2 | $519K | Hold |
5,928
| – | – | 0.06% | 59 |
|
|
2019
Q1 | $536K | Buy |
+5,928
| New | +$536K | 0.07% | 54 |
|